Posts by: admin

News

A study presented at the annual meeting of the American Society for Clinical Oncology has shown that DecisionDx-Melanoma (Castle Biosciences), a commercially available gene expression-profile (GEP) test, can be a useful ... Read more

October 20, 2014October 20, 2014

New Melanoma Drug Combination Improves Patient Survival Rate, According To Study

News

A recent study titled “Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma”, and presented at the 2014 European Society for Medical Oncology (ESMO) conference in Madrid, Spain, showed that patients with advanced ... Read more

October 16, 2014

Melanoma Treatment Benefits From Injecting Oncolytic Viruses

News

Research presented at the European Society for Medical Oncology (ESMO) Congress 2014, Madrid, Spain, has revealed that oncolytic viruses, such as specific common cold or herpes simplex viruses, can have ... Read more

October 8, 2014October 8, 2014

Provectus To Present PV-10 Clinical Data At The 2014 Beijing International Melanoma Congress

News

Provectus Biopharmaceuticals, Inc., a company specializing in developing oncology and dermatology therapies, has announced that clinical data on its investigative new drug PV-10 for the treatment of melanoma will be ... Read more

October 7, 2014

New Gigapixel High-Definition Camera For Skin Cancer Diagnosis

News

A team of researchers at Duke University in North Carolina, USA, have developed a gigapixel whole-body photographic camera capable of taking snapshots of the entire human body, enabling the caption ... Read more

October 6, 2014

Melanoma Incidence Linked to Socioeconomic Factors and Fashion Trends According to Study

News

A new study published in the American Journal of Public Health titled “More Skin, More Sun, More Tan, More Melanoma”, links cultural and historical forces to the increased incidence of ... Read more

October 3, 2014

Roche And GSK Melanoma Drug Combination Shows Similar Results

News

Results from recent clinical trials presented at the European Society of Medical Oncology annual congress in Madrid, showed that two of the new pill combinations for melanoma treatment from Roche ... Read more

October 2, 2014

Experimental Therapy Shows Promising Results in Melanoma

News

During the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain, data from a clinical study assessing pembrolizumab for the treatment of melanoma showed promising activity and safety profiles. ... Read more

September 30, 2014September 30, 2014

Array’s Melanoma Drug Promising in Phase 2 Study

Melanoma, News

Array BioPharma Inc. recently presented the latest results of its Phase 2 clinical trial of binimetinib in patients with advanced NRAS mutant melanoma, at the European Society for Medical Oncology (ESMO) Annual Meeting ... Read more

September 29, 2014September 29, 2014

FDA Grants Priority Review to Nivolumab For Melanoma Treatment

Melanoma, News

PD-1 inhibitor nivolumab (Opdivo) has been granted a priority review designation by the American Food and Drug Association (FDA), as a treatment for pretreated patients with advanced melanoma. This decision ... Read more

September 23, 2014September 23, 2014

PD-L1 in Melanoma Identified As Negative Prognostic Marker

Melanoma, News

In a new study entitled “PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics”, published in the Annals of Oncology journal, a ... Read more

September 22, 2014September 22, 2014

Melanoma Risk Associated with Telomere Length, According to Study

Melanoma, News

Researchers from the University of Leeds, have published a new study entitled “The effect on melanoma risk of genes previously associated with telomere length,” published in the Journal of the National ... Read more

September 18, 2014September 18, 2014

Study Shows Experimental Drug PV-10 Results In Complete Response In 50% Of Melanoma Patients

News

Two studies entitled “Efficacy of intralesional rose bengal in patients receiving injection in all existing melanoma in phase II study PV-10-MM-02” and “Assessment of immune and clinical efficacy after intralesional ... Read more

September 16, 2014September 16, 2014

Study Shows Possible Link between Viagra and Risk for Melanoma

Melanoma, News

A study entitled “Sildenafil Use and Increased Risk of Incident Melanoma in US Men, A Prospective Cohort Study” and published in the JAMA Internal Medicine journal has shown that there ... Read more

September 12, 2014September 12, 2014

Study Finds Link Between Genetic Mutation and Melanoma Progression

Melanoma, News

In a study entitled, “BRAFV600E melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity” published in the British Journal of Cancer, scientists from Dartmouth-Hitchcock Norris Cotton Cancer Center in ... Read more

September 10, 2014September 10, 2014

Melanoma Diagnosis Part of New, Advanced Broad-Spectrum Cancer Detection and Monitoring Platform

Melanoma, News

Aethlon Medical, Inc. and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), have announced that ESI researchers developed and validated a lectin-based diagnostic platform that can isolate exosome-based biomarkers common to several ... Read more

September 8, 2014September 8, 2014

Melanoma Risk Higher for Flight Crews, According to Study

Melanoma, News

A new study entitled “The Risk of Melanoma in Airline Pilots and Cabin Crew” published in the JAMA Dermatology journal has found that pilots and cabin crew members are 2.22 ... Read more

September 4, 2014September 4, 2014

New Handheld Device Allows Deeper Melanoma Screening

Melanoma, News

Researchers from Washington University in St. Louis have constructed a hand-held photoacoustic microscopy device that uses lasers and sound waves to measure how deep a melanoma tumor extends into the ... Read more

September 3, 2014September 3, 2014

Amgen Submits Marketing Authorization Application For New Melanoma Immunotherapy

Melanoma, News

Amgen, a biotechnology company developing innovative human therapeutics, has announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval for talimogene laherparepvec as a treatment ... Read more

September 2, 2014

New Melanoma Test Improves Reliability of Melanoma Diagnosis

News

Myriad Genetics, Inc, a leading molecular diagnostic company, has presented results from its pivotal clinical validation study of the Myriad myPath™ Melanoma test at the 2014 American Society of Clinical ... Read more